FMP
MaaT Pharma SA
MAAT.PA
EURONEXT
MaaT Pharma SA, a clinical stage company, engages in the research and development of microbiome biotherapies for the treatment of solid cancer tumors. Its products pipeline includes MaaT013 that has completed phase 2 clinical trials for the treatment of acute graft versus host diseases, as well as in preclinical trials to treat melanoma; MaaT033, which is in phase 1b clinical trials for the improvement of survival in patients with acute myeloid leukemia or other liquid tumors receiving allogeneic hematopoietic stem cell transplantation; and MaaT03X for the treatment of solid tumors. The company was incorporated in 2014 and is headquartered in Lyon, France.
8.94 EUR
0.04 (0.447%)
About
ceo
Mr. Herve Affagard
sector
Healthcare
industry
Biotechnology
website
https://www.maatpharma.com
exchange
EURONEXT
Description
MaaT Pharma SA, a clinical stage company, engages in the research and development of microbiome biotherapies for the treatment of solid cancer tumors. Its products pipeline includes MaaT013 that has completed phase 2 clinical trials for the treatment of acute graft versus host diseases, as well as in preclinical trials to treat melanoma; MaaT033, which is in phase 1b clinical trials for the improvement of survival in patients with acute myeloid leukemia or other liquid tumors receiving allogeneic hematopoietic stem cell transplantation; and MaaT03X for the treatment of solid tumors. The company was incorporated in 2014 and is headquartered in Lyon, France.
CIK
N/A
ISIN
FR0012634822
CUSIP
N/A
Address
70 Avenue Tony Garnier
Phone
33 4 28 29 14 00
Country
FR
Employee
52
IPO Date
Nov 8, 2021
Summary
CIK
-
Exchange
EURONEXT
Industry
Biotechnology
Sector
Healthcare
CUSIP
-
ISIN
FR0012634822
Country
FR
Price
8.94
Beta
0.25
Volume Avg.
1.63k
Market Cap
103.85M
Shares
-
52-Week
4.5-9.9
DCF
-4.5
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-5.26
P/B
-
Website
https://www.maatpharma.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest MAAT.PA News
It looks like there's no news available.
